Celemics, Inc.

Celemics, Inc. CELEMICS innovates NGS-based material with novel sequencing technology to disrupt the paradigm of me

01/06/2026

Weโ€™re excited to exhibit at in Gothenburg!

Join Celemics at ESHG 2026 to explore our NGS-based solutions for clinical genomics, target enrichment, and precision medicine research.

We look forward to seeing you at ESHG 2026!

27/05/2026

๐—ช๐—ต๐˜† ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—”๐—ฑ๐—ฎ๐—ฝ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ถ๐—ป๐—ด ๐˜€๐˜๐—ถ๐—น๐—น ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ฒ ๐˜€๐—ถ๐—ด๐—ป๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ป๐˜ ๐—ผ๐—ณ๐—ณ-๐˜๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ ๐—ฑ๐—ฎ๐˜๐—ฎ?
In Native DNA + Adaptive Sampling workflows, sequencing pores spend substantial resources rejecting non-target reads because the absolute proportion of target DNA remains low.

Our latest blog explores how combining Hybrid Target Enrichment with ONT Adaptive Sampling changes sequencing efficiency by increasing target density before sequencing begins.

๐—ž๐—ฒ๐˜† ๐—ผ๐—ฏ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€:
โ€ข Up to 96% on-target ratio with TE + AS
โ€ข Reduced uncovered regions across multiple cancer panels
โ€ข Higher mean depth coverage compared to conventional workflows
โ€ข Improved sequencing resource utilization for small target panels

Rather than replacing Target Enrichment, Adaptive Sampling becomes significantly more effective when combined with optimized enrichment workflows.

20/05/2026

Weโ€™re excited to join ASM Microbe 2026 in Washington, D.C.!

๐Ÿ“ Booth #1318
๐Ÿ“… June 5โ€“7, 2026
๐Ÿ“Œ Walter E. Washington Convention Center

Visit Celemics to explore our NGS-based solutions for pathogen detection, target enrichment, and infectious disease research.

We look forward to meeting you at ASM 2026!

19/05/2026
13/05/2026

๐—›๐—ผ๐˜„ ๐—ฐ๐—ฎ๐—ป ๐—ฐ๐˜‚๐˜€๐˜๐—ผ๐—บ ๐—ง๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ ๐—˜๐—ป๐—ฟ๐—ถ๐—ฐ๐—ต๐—บ๐—ฒ๐—ป๐˜ ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜… ๐—ฏ๐—ฟ๐—ฎ๐—ถ๐—ป ๐˜๐˜‚๐—บ๐—ผ๐—ฟ ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ๐˜€? Our latest blog highlights how Celemics custom Target Enrichment technology was applied in glioma research published in Science and Molecular Cancer.

โ€ข ultra-low VAF variant detection
โ€ข stable coverage across difficult genomic regions
โ€ข multi-platform NGS compatibility
โ€ข customized panel optimization for glioma-associated genes

Celemics designed and manufactured a custom panel targeting 15 glioma-related genes, supporting high-precision genomic analysis throughout the research workflow.

sequencing

16/04/2026

๐—›๐—ผ๐˜„ ๐—ฐ๐—ฎ๐—ป ๐—ผ๐—น๐—ถ๐—ด๐—ผ ๐—บ๐—ผ๐—ฑ๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—บ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฒ ๐—ก๐—š๐—ฆ ๐—ฝ๐—ฒ๐—ฟ๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐—ป๐—ฐ๐—ฒ?
From reducing adapter dimers to enhancing target capture efficiency, oligo design plays a critical role across the NGS workflow.
In our latest blog, we share how oligo modification improves both library preparation and sequencing performance.

26/03/2026

Weโ€™re excited to be part of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026!
Discover how Celemicsโ€™ NGS-based solutions enable sensitive and efficient pathogen detection:

โ–ช Target Enrichment for improved detection in host-dominant samples
โ–ช Reliable analysis of complex and mixed samples
โ–ช NGS-based pathogen surveillance for public health and research

Meet our team in Munich and explore how we support infectious disease research with high-sensitivity, targeted sequencing solutions.

targetenrichment viralgenomics

20/03/2026

New blog is live ๐Ÿ“ข If youโ€˜re working with ๐—ข๐—ก๐—ง ๐—น๐—ผ๐—ป๐—ด-๐—ฟ๐—ฒ๐—ฎ๐—ฑ ๐˜€๐—ฒ๐—พ๐˜‚๐—ฒ๐—ป๐—ฐ๐—ถ๐—ป๐—ด, having the right workflow can make a real difference.
provides an optimized targeted sequencing workflow for Oxford Nanopore Technologies (hashtag ) platform users, integrating:
โœ” Long-read library preparation
โœ” Target enrichment for improved on-target efficiency
โœ” Multiplexing strategies for enhanced per-sample cost efficiency
โœ” Robust structural variant detection and full-length gene analysis

11/03/2026

๐Ÿงฌ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ๐— ๐—ฎ๐˜€๐˜๐—ฒ๐—ฟโ„ข โ€“ ๐—” ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น๐—น๐˜† ๐—ฉ๐—ฎ๐—น๐—ถ๐—ฑ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—œ๐—ป๐˜๐—ฒ๐—ด๐—ฟ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ก๐—š๐—ฆ ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐—ณ๐—ผ๐—ฟ ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜†
CancerMasterโ„ข, a 524-gene hybrid capture NGS panel developed by Celemics, has been analytically and clinically validated using real-world patient data from Severance Hospital.
The study demonstrates high concordance with TSO500, deep sequencing performance (~1,200ร— coverage), and integrated analysis of SNV, CNV, Fusion, MSI, TMB, and viral biomarkers.

24/02/2026

๐—Ÿ๐—ผ๐—ผ๐—ธ๐—ถ๐—ป๐—ด ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐——๐—ก๐—” ๐—–๐—น๐—ฒ๐—ฎ๐—ป-๐˜‚๐—ฝ ๐—•๐—ฒ๐—ฎ๐—ฑ? ๐—ฌ๐—ผ๐˜‚โ€™๐˜ƒ๐—ฒ ๐—ท๐˜‚๐˜€๐˜ ๐—ณ๐—ผ๐˜‚๐—ป๐—ฑ ๐—ถ๐˜.
๐Ÿ”— Inquiry & Product Information: https://lnkd.in/gAPddzJC

CeleMagโ„ข Clean-up Bead is optimized for NGS library preparation, delivering reliable DNA purification and flexible size selection across workflows.
โœ” Magnetic bead-based purification
โœ” High DNA recovery with minimized sample loss
โœ” Adjustable bead-to-sample ratio for precise size selection
โœ” Compatible with diverse NGS library prep workflows

Designed to support reproducibility and consistency in demanding research environments, CeleMagโ„ข Clean-up Bead provides stable performance you can rely on.

Address

19F~20F, Bldg. A, BYC Highcity, 131 Gasandigital 1-ro, Geumcheon-gu
Gwangmyeong
08506

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+82267468067

Alerts

Be the first to know and let us send you an email when Celemics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Celemics, Inc.:

Share